Document is current

Any future updates will be listed below

Study of Aldo-keto Reductase 1C3 Inhibitor with Novel Framework for Treating Leukaemia Based on Virtual Screening and In vitro Biological Activity Testing

Crossref DOI link: https://doi.org/10.1007/s40242-021-0279-3

Published Online: 2021-01-14

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark